Скачать или смотреть Telix Pharmaceuticals TLX Class Action Lawsuit: Secure Your Rights Before Deadline

Telix Pharmaceuticals class action lawsuit TLX stock investors securities fraud
Discover why Rosen Law Firm, the first to file, is urging Telix Pharmaceuticals Ltd. (NASDAQ: TLX) investors to act now. This video covers the key details of the securities class action lawsuit filed on behalf of purchasers of TLX securities from February 21, 2025, to August 28, 2025.
Learn about the allegations that defendants overstated progress on prostate cancer therapeutic candidates and the quality of Telix's supply chain and partners, leading to misleading statements that impacted stock prices and caused investor losses.
If you bought TLX shares during the class period, you may be entitled to compensation through a contingency fee arrangement without out-of-pocket costs. The deadline to move to serve as lead plaintiff is January 9, 2026.
We'll explain what to do next, why choosing experienced counsel like Rosen Law Firm matters, and how to join the class action. Rosen Law Firm has a proven track record, ranking No. 1 in securities class action settlements in 2017 and recovering hundreds of millions for investors.
Stay informed and protect your investment rights in this Telix class action update.